First published in Clinical Pharmacology in Drug Development on 2016 Nov.Clin Pharmacol Drug Dev. 2016 Nov;5(6):488-501. doi: 10.1002/cpharmacodynamicsd.263. Authors: Heinig...
Read Article
This open-label, nonrandomized, single-dose, phase 1 study evaluated the pharmacokinetics and safety of murepavadin, a novel peptide antibiotic for the treatment of serious Pseudomonas aeruginosa infections.